News & Analysis on Clinical Trial Services & Contract Research And Development
A proposed prescription drug price cap in the wake of the Turing Pharmaceuticals controversy will lead to reductions in R&D spending and could have a negative knock-on effect for CROs say experts.
Recipharm will cut jobs to reduce costs after lower customer demand.
Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.
US compounder Pharmedium has recalled sterile drugs made with contaminated saline supplied by Pfizer's Hospira unit.
Sanofi has confirmed it wants to sell the Kansas City facility at which it makes the allergy drug Allegra (Fexofenadine).
Trilantic Capital Partners Europe has bought a majority stake in Doppel Farmaceutici, citing the growth potential of Europe’s contracting market as the driver.